H. Prentice

发表

Cumulative Impact of Host and Viral Factors on HIV-1 Viral-Load Control during Early Infection

P. Goepfert, S. Allen, E. Hunter, 2012, Journal of Virology.

HLA-B*57 versus HLA-B*81 in HIV-1 Infection: Slow and Steady Wins the Race?

A. Kamali, E. Karita, S. Allen, 2013, Journal of Virology.

HLA-B(star)57 versus HLA-B(star)81 in HIV-1 Infection: Slow and Steady Wins the Race?

A. Kamali, E. Karita, S. Allen, 2022 .

Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.

A. Kamali, E. Karita, M. Mugavero, 2014, Virology.

Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis

David Heckerman, Tianwei Yu, Jonathan M. Carlson, 2012, PLoS pathogens.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial

Jerome H. Kim, C. Andrews, M. Robb, 2014, Immunogenetics.

Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection

A. Kamali, E. Karita, P. Goepfert, 2016, Journal of Virology.

HIV-1 Dynamics: A Reappraisal of Host and Viral Factors, as well as Methodological Issues

Jianming Tang, H. Prentice, 2012, Viruses.

HIGH DENSITY GENOTYPING FOR IMMUNOGENETIC POLYMORPHISMS ASSOCIATED WITH TRANSMISSION AND CONTROL OF HIV-1 INFECTION IN ZAMBIAN HETEROSEXUAL SERODISCORDANT COUPLES

R. Kaslow, Kui Zhang, N. Pajewski, 2013 .

Human Leukocyte Antigen Variants B*44 and B*57 Are Consistently Favorable during Two Distinct Phases of Primary HIV-1 Infection in Sub-Saharan Africans with Several Viral Subtypes

A. Kamali, E. Karita, S. Allen, 2011, Journal of Virology.

Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy

S. Shrestha, A. Bansal, H. Wiener, 2018, Front. Public Health.

Immunogenetic influences on acquisition of HIV-1 infection: Consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2)

S. Allen, E. Hunter, I. Brill, 2015, Genes and Immunity.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial

Jerome H. Kim, C. Andrews, M. Robb, 2014, Immunogenetics.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

Allan C. deCamp, Jerome H. Kim, S. Zolla-Pazner, 2015, Science Translational Medicine.

Host genetics and immune control of HIV-1 infection: Fine mapping for the extended human MHC region in an African cohort

S. Allen, E. Hunter, R. Kaslow, 2014, Genes and Immunity.

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

S. Rerks-Ngarm, S. Nitayaphan, J. Kaewkungwal, 2015, Tissue antigens.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, H. Liao, 2014, The Journal of clinical investigation.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, B. Haynes, 2014, The Journal of clinical investigation.